Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Urology
Published in: BMC Urology 1/2015

Open Access 01-12-2015 | Research article

Urethral orifice hyaluronic acid injections: a novel animal model of bladder outlet obstruction

Authors: Yongquan Wang, Zhiyong Xiong, Wei Gong, Zhansong Zhou, Gensheng Lu

Published in: BMC Urology | Issue 1/2015

Login to get access

Abstract

Background

We produced a novel model of bladder outlet obstruction (BOO) by periurethral injection of hyaluronic acid and compared the cystometric features, postoperative complications, and histopathological changes of that model with that of traditional open surgery.

Methods

Forty female Sprague-Dawley rats were divided into three groups. Fifteen rats were subcutaneously injected with 0.2 ml hyaluronic acid at 5, 7, and 12 o’clock around the urethral orifice. Another fifteen rats underwent traditional open partial proximal urethral obstruction surgery, and 10 normal rats used as controls. After 4 weeks, filling cystometry, postoperative complications, and histopathological features were evaluated in each group. Three rats were also observed for 12 weeks after hyaluronic acid injection to evaluate the long-term effect.

Results

Hyaluronic acid periurethral injection caused increased maximum cystometric capacity, maximum bladder pressure, micturition interval, and post-void residual urine volume compared with control (p < 0.01). The injection group had significantly shorter operative time, less incidence of incision infection and bladder stone formation compared with the surgery group (p < 0.01). Hematoxylin and eosin (HE) staining showed suburothelial and interstitial hyperemia edema and smooth muscle hypertrophy in both injection and surgery bladders; these were not observed in the control group. Bladder weight and thickness of smooth muscle in the injection and surgery groups were significantly greater than those in the control group (p < 0.01). Urethral epithelial hyperplasia and lamina propria inflammation were observed in the surgery group but not in the injection or control groups. Rats periurethrally injected hyaluronic acid were stable the compound was not fully absorbed in any rat after 12 weeks.

Conclusions

Hyaluronic acid periurethral injection generates a simple, effective, and persistent animal model of BOO with lower complications, compared with traditional surgery.
Literature
1.
Griebling TL. Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence, and bladder outlet obstruction. BJU Int. 2011;108:1138–9.CrossRefPubMed
2.
Starkman JS, Duffy 3rd JW, Wolter CE, Kaufman MR, Scarpero HM, Dmochowski RR. The evolution of obstruction induced overactive bladder symptoms following urethrolysis for female bladder outlet obstruction. J Urol. 2008;179:1018–23.CrossRefPubMed
3.
4.
Tanaka H, Kakizaki H, Shibata T, Mitsui T, Koyanagi T. Effect of preemptive treatment of capsaicin or resiniferatoxin on the development of pre-micturition contractions after partial urethral obstruction in the rat. J Urol. 2003;170:1022–6.CrossRefPubMed
5.
Austin JC, Chacko SK, DiSanto M, Canning DA, Zderic SA. A male murine model of partial bladder outlet obstruction reveals changes in detrusor morphology, contractility and Myosin isoform expression. J Urol. 2004;172(4 Pt 1):1524–8.CrossRefPubMed
6.
Gur S, Sikka SC, Chandra S, Koka PS, Agrawal KC, Kadowitz PJ, et al. Alfuzosin attenuates erectile dysfunction in rats with partial bladder outlet obstruction. BJU Int. 2008;102:1651–7.CrossRefPubMed
7.
Santis WF, Sullivan MP, Gobet R, Cisek LJ, McGoldrick RJ, Yalla SV, et al. Characterization of ureteral dysfunction in an experimental model of congenital bladder outlet obstruction. J Urol. 2000;163:980–4.CrossRefPubMed
8.
Burmeister D, AbouShwareb T, D'Agostino Jr R, Andersson KE, Christ GJ. Impact of partial urethral obstruction on bladder function: time-dependent changes and functional correlates of altered expression of Ca2+ signaling regulators. Am J Physiol Renal Physiol. 2012;302:1517–28.CrossRef
9.
Jang H, Han DS, Yuk SM. Changes of neuregulin-1(NRG-1) expression in a rat model of overactive bladder induced by partial urethral obstruction: is NRG-1 a new biomarker of overactive bladder? BMC Urol. 2013;13:54–9.CrossRefPubMedPubMedCentral
10.
Yuan X, Wu S, Lin T, He D, Li X, Liu S, et al. Role of nitric oxide synthase in bladder pathologic remodeling and dysfunction resulting from partial outlet obstruction. Urology. 2011;77:1001–8.CrossRef
11.
Benshushan A, Brzezinski A, Shoshani O, Rojansky N. Periurethral injection for the treatment of urinary incontinence. Obstet Gynecol Surv. 1998;53:383–8.CrossRefPubMed
12.
Kim SO, Oh BS, Chang IY, Song SH, Ahn K, Hwang EC, et al. Distribution of interstitial cells of Cajal and expression of nitric oxide synthase after experimental bladder outlet obstruction in a rat model of bladder overactivity. Neurourol Urodyn. 2011;30:1639–45.CrossRefPubMed
13.
Buttyan R, Chen MW, Levin RM. Animal models of bladder outlet obstruction and molecular insights into the basis for the development of bladder dysfunction. Eur Urol. 1997;32 Suppl 1:32–9.PubMed
14.
O'Connor Jr LT, Vaughan Jr ED, Felsen D. In vivo cystometric evaluation of progressive bladder outlet obstruction in rats. J Urol. 1997;158:631–5.CrossRefPubMed
15.
McKinney CD, Gaffey MJ, Gillenwater JY. Bladder outlet obstruction after multiple periurethral polytetrafluoroethylene injections. J Urol. 1995;153:149–51.CrossRefPubMed
16.
Mintz BR, Cooper Jr JA. Hybrid hyaluronic acid hydrogel/poly(varepsilon-caprolactone) scaffold provides mechanically favorable platform for cartilage tissue engineering studies. J Biomed Mater Res A. 2014;102:2918–26.CrossRefPubMed
17.
Kohn JC, Goh AS, Lin JL, Goldberg RA. Dynamic High-Resolution Ultrasound In Vivo Imaging of Hyaluronic Acid Filler Injection. Dermatol Surg. 2013;39:1630–6.CrossRefPubMed
18.
DaJusta D, Gargollo P, Snodgrass W. Dextranomer/hyaluronic acid bladder neck injection for persistent outlet incompetency after sling procedures in children with neurogenic urinary incontinence. J Pediatr Urol. 2013;9:278–82.CrossRefPubMed
19.
Beasley KL, Weiss MA, Weiss RA. Hyaluronic acid fillers: a comprehensive review. Facial Plast Surg. 2009;25:86–94.CrossRefPubMed
Metadata
Title
Urethral orifice hyaluronic acid injections: a novel animal model of bladder outlet obstruction
Authors
Yongquan Wang
Zhiyong Xiong
Wei Gong
Zhansong Zhou
Gensheng Lu
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Urology / Issue 1/2015
Electronic ISSN: 1471-2490
DOI
https://doi.org/10.1186/s12894-015-0002-0

Other articles of this Issue 1/2015

BMC Urology 1/2015 Go to the issue

Research article

Oncologic outcomes in men with metastasis to the prostatic anterior fat pad lymph nodes: a multi-institution international study

Research article

Changes in the Q-tip angle in relation to the patient position and bladder filling

Research article

Simultaneous retrograde intrarenal surgery for ipsilateral asymptomatic renal stones in patients with ureteroscopic symptomatic ureteral stone removal

Research article

Treatment of renal angiomyolipoma: pooled analysis of individual patient data

Research article

High acceptability of a newly developed urological practical skills training program

Database

An online tool for evaluating diagnostic and prognostic gene expression biomarkers in bladder cancer